196 related articles for article (PubMed ID: 27392855)
21. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
22. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.
Yarchoan M; James BD; Shah RC; Arvanitakis Z; Wilson RS; Schneider J; Bennett DA; Arnold SE
J Alzheimers Dis; 2017; 56(2):699-706. PubMed ID: 28035936
[TBL] [Abstract][Full Text] [Related]
23. Neuritic and Diffuse Plaque Associations with Memory in Non-Cognitively Impaired Elderly.
Malek-Ahmadi M; Perez SE; Chen K; Mufson EJ
J Alzheimers Dis; 2016 Jul; 53(4):1641-52. PubMed ID: 27540968
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.
Lippa CF; Smith TW; Saunders AM; Hulette C; Pulaski-Salo D; Roses AD
Neurology; 1997 Feb; 48(2):515-9. PubMed ID: 9040748
[TBL] [Abstract][Full Text] [Related]
26. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Cheng YC; Huang YC; Liu HC
Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
[TBL] [Abstract][Full Text] [Related]
27. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.
Glöckner F; Meske V; Ohm TG
Neuroscience; 2002; 114(4):1103-14. PubMed ID: 12379263
[TBL] [Abstract][Full Text] [Related]
28. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
29. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
30. Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study.
Falsetti L; Viticchi G; Buratti L; Grigioni F; Capucci A; Silvestrini M
J Alzheimers Dis; 2018; 62(2):713-725. PubMed ID: 29480173
[TBL] [Abstract][Full Text] [Related]
31. Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer's Disease.
Oleson S; Murphy C
J Alzheimers Dis; 2015; 46(3):791-803. PubMed ID: 25869786
[TBL] [Abstract][Full Text] [Related]
32. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
33. Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results.
Moreno-Grau S; Rodríguez-Gómez O; Sanabria Á; Pérez-Cordón A; Sánchez-Ruiz D; Abdelnour C; Valero S; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Lafuente A; Gil S; Santos-Santos MÁ; Alegret M; Espinosa A; Ortega G; Guitart M; Gailhajanet A; de Rojas I; Sotolongo-Grau Ó; Ruiz S; Aguilera N; Papasey J; Martín E; Peleja E; ; Lomeña F; Campos F; Vivas A; Gómez-Chiari M; Tejero MÁ; Giménez J; Serrano-Ríos M; Orellana A; Tárraga L; Ruiz A; Boada M;
Alzheimers Dement; 2018 May; 14(5):634-643. PubMed ID: 29156223
[TBL] [Abstract][Full Text] [Related]
34. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
35. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.
Bangen KJ; Beiser A; Delano-Wood L; Nation DA; Lamar M; Libon DJ; Bondi MW; Seshadri S; Wolf PA; Au R
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1361-9. PubMed ID: 23601373
[TBL] [Abstract][Full Text] [Related]
36. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
[TBL] [Abstract][Full Text] [Related]
38. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
39. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
Jellinger KA; Attems J
Acta Neuropathol; 2007 Feb; 113(2):107-17. PubMed ID: 17089134
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs.
Parcon PA; Balasubramaniam M; Ayyadevara S; Jones RA; Liu L; Shmookler Reis RJ; Barger SW; Mrak RE; Griffin WST
Alzheimers Dement; 2018 Feb; 14(2):230-242. PubMed ID: 28945989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
